Key design considerations for adaptive clinical trials: A primer for clinicians

BMJ (Online)

Volumn 360, Issue , 2018, Pages

  Thorlund, Kristian ^a,b   Haggstrom, Jonas ^b   Park, Jay Jh ^a   Mills, Edward J ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DRUG SCREENING; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS DESIGN; PROGRESSION FREE SURVIVAL; REVIEW; RISK BENEFIT ANALYSIS; SAMPLE SIZE; SIMULATION; STUDY DESIGN; SURVIVAL ANALYSIS; CLINICAL TRIAL (TOPIC); METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; REPRODUCIBILITY; STANDARDS; STATISTICAL ANALYSIS; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; GUIDELINES AS TOPIC; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; UNITED STATES;

EID: 85043579232     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.k698     Document Type: Review

References (12)

1. European Medicines Agency. Adaptive pathways 2017 http://www. ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/ general-content-000601.jsp.
2. United States Food and Drug Administration. Adaptive designs for medical device clinical studies., 2016. https://www.fda.gov/ downloads/medicaldevices/deviceregulationandguidance/ guidancedocuments/ucm446729.pdf
3. Guyatt GH, Mills EJ, Elbourne D. In the era of systematic reviews, does the size of an individual trial still matter. PLoS Med 2008;5:e4. 10.1371/journal.pmed.0050004
4. Bauer P, Koenig F. The reassessment of trial perspectives from interim data-a critical view. Stat Med 2006;25:23-36. 10.1002/ sim.2180
5. Ning J, Huang X. Response-adaptive randomization for clinical trials with adjustment for covariate imbalance. Stat Med 2010;29:1761-8. 10.1002/sim.3978
6. Simon N, Simon R. Adaptive enrichment designs for clinical trials. Biostatistics 2013;14:613-25. 10.1093/biostatistics/kxt010
7. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56. 10.2307/2530245
8. Hummel J, Wang S, Kirkpatrick J. Using simulation to optimize adaptive trial designs: Applications in learning and confirmatory phase trials. Clin Investig (Lond) 2015;5:401-1310.4155/cli.15.14.
9. Antonijevic Z, Kimber M, Manner K, Burman C, Pinheiro J, Bergenheim K. Optimizing Drug Development Programs. Ther Innov Regul Sci 2013;47:710.1177/2168479013480501.
10. Bornkamp B, Bretz F, Dmitrienko A, et al. Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat 2007;17:965-95. 10.1080/10543400701643848
11. Atkinson AC, Biswas A. Randomised response-adaptive designs in clinical trials. CRC Press, 2013.
12. Wason JM, Abraham JE, Baird RD, et al. A Bayesian adaptive design for biomarker trials with linked treatments. Br J Cancer 2015;113:699-705. 10.1038/bjc.2015.278